Researchers discover antibody that may help detect ovarian cancer in earliest stages

Using a new approach to developing biomarkers for the very early detection of ovarian cancer, researchers at Rush University Medical Center have identified a molecule in the bloodstream of infertile women that could one day be used to screen for those at high risk for the disease — or even those with early-stage ovarian cancer.

Read the whole article on Physorg

More from Physorg